pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
LACTIN-V
Bacterial Vaginosis
Osel Inc
0
catalysts
LACTULOSE SOLUTION
LACTULOSE SOLUTION (LACTULOSE SOLUTION USP, 10 G/15 ML)
BAJAJ
0
catalysts
Preclinical
LADR-7
Head And Neck Squamous Cell Carcinoma (HNSC)
LadRx Corp
0
catalysts
Phase 1
LAE-102
Obesity
Laekna Inc
catalysts
← prev
page 102 of 231
next →
131
Pain
89
Neurology
1
0
LAMIVUDINE AND ZIDOVUDINE
LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)
MACLEODS PHARMS LTD
0
catalysts
LARIN 1.5/30
LARIN 1.5/30 (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL)
NOVAST LABS
0
catalysts
Phase 2
LASN-01
Graves' Ophthalmopathy
Lassen Therapeutics 1 Inc
0
catalysts
Phase 2
LAT-010
Breast Cancer
Latticon Antibody Therapeutics Inc
0
catalysts
Phase 2
LB-100
Myelodysplastic Syndrome (Preleukemia)
Serine/threonine-protein phosphatase 5
Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
$LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
0
catalysts
Phase 3
LB-102
Schizophrenia
$LBRX
LB PHARMACEUTICALS INC
0
catalysts
Preclinical
LB-104
Depression
$LBRX
LB PHARMACEUTICALS INC
0
catalysts
Phase 1
LB-1908
Adenocarcinoma Of The Gastroesophageal Junction
$LEGN
Legend Biotech Corp
0
catalysts
Phase 2
LB-2102
Neuroendocrine Carcinoma
$NVS
NOVARTIS AG
0
catalysts
Preclinical
LB-P4
Alzheimer's Disease
LISCure Biosciences Inc
0
catalysts
Phase 2
LB-P8
Primary Sclerosing Cholangitis
LISCure Biosciences Inc
0
catalysts
Preclinical
LBL-043
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Nanjing Leads Biolabs Co Ltd
0
catalysts
Preclinical
LBL-049
Cancer Anorexia-Cachexia Syndrome
Nanjing Leads Biolabs Co Ltd
0
catalysts
Preclinical
LBL-051
Lupus Nephritis
Nanjing Leads Biolabs Co Ltd
0
catalysts
Preclinical
LBL-061
Head And Neck Squamous Cell Carcinoma (HNSC)
Nanjing Leads Biolabs Co Ltd
0
catalysts
Preclinical
LBP-02
Ulcerative Colitis
Shenzhen UnknownBio Biotechnology Co Ltd
0
catalysts
Phase 2
LBPEC-01
Escherichia coli Infections
Locus Biosciences Inc
0
catalysts
Phase 1
LBX-200
Inherited Metabolic Disorders
Liberyx Therapeutics Ltd
0
catalysts
Preclinical
LCB-39
Breast Cancer
LigaChem Biosciences Inc
0
catalysts
Phase 2
LCB-71
Diffuse Large B-Cell Lymphoma
CStone Pharmaceuticals Co Ltd
0
catalysts
Preclinical
LCTG-001
Common Variable Immunodeficiency (CVID)
Lactiga Inc
0
catalysts
LEADER 12 HOUR SINUS NASAL DECONGESTANT
LEADER 12 HOUR SINUS NASAL DECONGESTANT (PSEUDOEPHEDRINE HCL)
L PERRIGO CO
0
catalysts
LEDIPASVIR AND SOFOSBUVIR
LEDIPASVIR AND SOFOSBUVIR (LEDIPASVIR AND SOFOSBUVIR)
GILEAD SCIENCES INC
0
catalysts
LEVALBUTEROL
LEVALBUTEROL (LEVALBUTEROL)
LUOXIN AUROVITAS
0
catalysts
LEVONORGETSREL AND ETHINYL ESTRADIOL
LEVONORGETSREL AND ETHINYL ESTRADIOL (LEVONORGETSREL AND ETHINYL ESTRADIOL)
HETERO LABS
0
catalysts
Phase 2
LG-631
Glioblastoma Multiforme (GBM)
Lentigen Technology Inc
0
catalysts
